Dr. Shum on Emerging Targeted Therapies in EGFR-Mutant NSCLC
Elaine Shum, MD, discusses emerging targeted therapies in EGFR-mutant non–small cell lung cancer.
Dr. Shum on Patient Consultation of Osimertinib in NSCLC
Elaine Shum, MD, discusses consulting patients with non-small cell lung cancer on the use of osimertinib.
Dr. Shum Discusses Dacomitinib in EGFR+ NSCLC
Elaine Shum, MD, medical oncologist, NYU Langone’s Perlmutter Cancer Center, discusses the use of dacomitinib in the treatment of patients with EGFR-positive non–small cell lung cancer.
Dr. Shum on Mechanisms of Resistance in Oncogene-Driven NSCLC
Elaine Shum, MD, medical oncologist, NYU Langone’s Perlmutter Cancer Center, discusses mechanisms of resistance in patients with oncogene-driven non–small cell lung cancer (NSCLC).
Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care
Dr Habib on Developments in Palliative Care For Patients With Cancer
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations
2 Clarke Drive Cranbury, NJ 08512